1887

Abstract

The RNA-binding activity of influenza A virus M1 protein was studied by cross-linking the protein to viral RNA followed by sequence analysis of the oligoribonucleotide bound to the protein as well as sequence analysis of the M1 peptide bound to the RNA. M1 was found to bind to RNA without any RNA sequence specificity, as verified in a series of filterbinding experiments using a large variety of nucleic acids including DNA. The peptide sequence that bound to the RNA was the RKLKR nuclear localization signal of M1. Site-specific mutagenesis of recombinant M1 showed that most of the basic residues in that region had to be mutated in order to inhibit RNA-binding. We also constructed an M1 mutant that no longer bound to RNA but which was still able to inhibit the transcription activity of isolated viral ribonucleoprotein, albeit to a lower extent. Mutation of the zinc-binding sequence had no effect on RNA-binding or transcription-inhibition activity.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-7-1589
1997-07-01
2024-12-10
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/7/9225034.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-7-1589&mimeType=html&fmt=ahah

References

  1. Baudin F., Romby P., Romaniuk P. J., Ehresmann B., Ehresmann C. 1989; Crosslinking of transcription factor TFIIIA to ribosomal 5S RNA from X. laevis by trans-diammine dichloroplatinum (II). Nucleic Acids Research 17:10035–10046
    [Google Scholar]
  2. Baudin F., Bach C., Cusack S., Ruigrok R. W. H. 1994; Structure of influenza virus RNP. I. Influenza virus nucleoprotein melts secondary structure in panhandle RNA and exposes the bases to the solvent. EMBO Journal 13:3158–3165
    [Google Scholar]
  3. Bucher D. J., Kharitonenkov I. G., Zakomirdin J. A., Grigoriev V. B., Klimenko S. M., Davis J. F. 1980; Incorporation of influenza virus M-protein into liposomes. Journal of Virology 36:586–590
    [Google Scholar]
  4. Bui M., Whittaker G., Helenius A. 1996; Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. Journal of Virology 70:8391–8401
    [Google Scholar]
  5. Bukrinskaya A. G., Vorkunova N. K., Kornilayeva G. V., Narman-betova R. A., Vorkunova G. K. 1982; Influenza virus uncoating in infected cells and effect of rimantadine. Journal of General Virology 60:49–59
    [Google Scholar]
  6. Burd C. G., Dreyfuss G. 1994; Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615–621
    [Google Scholar]
  7. Ehresmann C., Moine H., Mougel M., Dondon J., Grunberg-Manago M., Ebel J. P., Ehresmann B. 1986; Cross-linking of initiation factor IF3 to Escherichia coli 30S ribosomal subunit by trans-diammine- dichloroplatinum(II): characterization of two cross-linking sites in 16S rRNA; a possible way. Nucleic Acids Research 14:4803–4821
    [Google Scholar]
  8. Elster C., Fourest E., Baudin F., Larsen K., Cusack S., Ruigrok R. W. H. 1994; A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction. Journal of General Virology 75:37–42
    [Google Scholar]
  9. Enami M., Enami K. 1996; Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. Journal of Virology 70:6653–6657
    [Google Scholar]
  10. Gregoriades A., Frangione B. 1981; Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. Journal of Virology 40:323–328
    [Google Scholar]
  11. Hankins R. W., Nagata K., Kato A., Ishihama A. 1990; Mechanism ofinfluenza virus transcription inhibition by matrix (Ml) protein. Research in Virology 141:305–314
    [Google Scholar]
  12. Hay A. J. 1989; The mechanism of action of amantadine and rimantadine against influenza viruses. In Concepts in Viral Pathogenesis III pp 361–367 Notkins A. L., Oldstone M. B. A. Edited by New York: Springer Verlag;
    [Google Scholar]
  13. Hay A. J., Skehel J. J. 1975; Studies on the synthesis of influenza virus proteins. In Negative Strand Viruses pp 635–655 Mahy B. W. J., Barry R. D. Edited by London: Academic Press;
    [Google Scholar]
  14. Jin H., Leser G. P., Lamb R. A. 1994; The influenza virus haemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO Journal 13:5504–5515
    [Google Scholar]
  15. Kretzchmar E., Bui M., Rose J. K. 1996; Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology 220:37–45
    [Google Scholar]
  16. LaCasse E. C., Lefebvre Y. A. 1995; Nuclear localisation signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Research 23:1647–1656
    [Google Scholar]
  17. Martin K., Helenius A. 1991a; Transport ofincoming influenza virus nucleocapsids into the nucleus. Journal of Virology 65:232–244
    [Google Scholar]
  18. Martin K., Helenius A. 1991b; Nuclear transport of influenza virus ribonucleoproteins : the viral matrix protein (M1) promotes export and inhibits import. Cell 67:117–130
    [Google Scholar]
  19. Maxam A. M., Gilbert W. 1977; A new method for sequencing DNA. Proceedings of the National Academy of Sciences USA: 74560–564
    [Google Scholar]
  20. Méric C., Goff S. P. 1989; Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. Journal of Virology 63:1558–1568
    [Google Scholar]
  21. Moine H., Bienaimé C., Mougel M., Reinbolt J., Ebel J. P., Ehresmann C., Ehresmann B. 1988; Crosslinking of ribosomal protein S18 to 16 S RNA in E . coli ribosomal 30 S subunits by the use of a reversible crosslinking agent : trans-diamminedichloroplatinum (II). FEBS Letters 228:1–6
    [Google Scholar]
  22. Nasser E. H., Judd A. K., Sanchez A., Anastasiou D., Bucher D. 1996; Antiviral activity of influenza virus M1 zinc finger peptides. Journal of Virology 70:8639–8644
    [Google Scholar]
  23. Pinto L. H., Holsinger L. J., Lamb R. A. 1992; Influenza virus M2 protein has ion channel activity. Cell 69:517–528
    [Google Scholar]
  24. Politz S. M., Noller H. F., McWhirter P. D. 1981; Ribonucleic acid- protein crosslinking in Escherichia coli ribosomes : (4-azidophenyl)glyoxal, a novel heterobifunctional reagent. Biochemistry 20:372–378
    [Google Scholar]
  25. Rey O., Nayak D. P. 1992; Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear transport of viral ribonucleoproteins. Journal of Virology 66:5815–5824
    [Google Scholar]
  26. Ruigrok R. W. H., Calder L. J., Wharton S. A. 1989; Electron microscopy of the influenza virus submembranal structure. Virology 173:311–316
    [Google Scholar]
  27. Sgro J. Y., Jacrot B., Chroboczek J. 1986; Identification of regions of brome mosaic virus coat protein chemically cross-linked in situ to viral RNA. European Journal of Biochemistry 154:69–76
    [Google Scholar]
  28. Silberklang M., Gillum A. M., RajBhandary U. L. 1977; The use of nuclease P1in sequence analysis of end-group labeled RNA. Nucleic Acids Research 4:4090–4108
    [Google Scholar]
  29. Tukalo M. A., Kubler M. D., Kern D., Mougel M., Ehresmann C., Ebel J. P., Ehresmann B., Giegé R. 1987; trans-Diammine- dichloroplatinum(II), a reversible RNA-protein cross-linking agent. Application to the ribosome and to an aminoacyl-tRNA synthetase/ tRNA complex. Biochemistry 26:5200–5208
    [Google Scholar]
  30. Wakefield L., Brownlee G. G. 1989; RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Research 17:8569–8580
    [Google Scholar]
  31. Watanabe K., Handa H., Mizumoto K., Nagata K. 1996; Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. Journal of Virology 70:241–247
    [Google Scholar]
  32. Wharton S. A., Hay A. J., Sugrue R. J., Skehel J. J., Weis W. I., Wiley D. C. 1990 In Use of X-ray Crystallography in the Design of Antiviral Agents pp 1–12 Laver W. G., Air G. M. Edited by Orlando: Academic Press;
    [Google Scholar]
  33. Whittaker G., Kemler I., Helenius A. 1995; Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus. Journal of Virology 69:439–445
    [Google Scholar]
  34. Whittaker G., Bui M., Helenius A. 1996; Nuclear traffic of influenza virus ribonucleoproteins in heterokaryons. Journal of Virology 70:2743–2756
    [Google Scholar]
  35. Wikman F. P., Romby P., Metz M. H., Reinbolt J., Clark B. F. C., Ebel J. P., Ehresmann C., Ehresmann B. 1987; Crosslinking of elongation factor Tu to tRNA(Phe) by trans-diamminedichloroplatinum (II). Characterization of two crosslinking sites in the tRNA. Nucleic Acids Research 15:5787–5801
    [Google Scholar]
  36. Ye Z., Pal R., Fox J. W., Wagner R. R. 1987; Functional and antigenic domains of the matrix (M1) protein of influenza A virus. Journal of Virology 61:239–246
    [Google Scholar]
  37. Ye Z., Baylor N. W., Wagner R. R. 1989; Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. Journal of Virology 63:3586–3594
    [Google Scholar]
  38. Ye Z., Robinson D., Wagner R. R. 1995; Nucleus-targeting domain of the matrix protein (M1) of infuenza virus. Journal of Virology 69:1964–1970
    [Google Scholar]
  39. Zebedee S. L., Lamb R. A. 1988; Infuenza virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. Journal of Virology 62:2762–2772
    [Google Scholar]
  40. Zhang J., Lamb R. A. 1996; Characterization of the membrane association of the infuenza virus matrix protein in living cells. Virology 225:255–266
    [Google Scholar]
  41. Zvonarjev A. Y., Ghendon Y. Z. 1980; Infuence of membrane (M) protein on in?uenza virion transcription activity in vitro and its susceptibility to rimantadine. Journal of Virology 33:583–586
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-78-7-1589
Loading
/content/journal/jgv/10.1099/0022-1317-78-7-1589
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error